Hanmi Pharmaceutical Co., Ltd. - Insider Trading & Ownership

Location
14, Wiryeseong Daero, Songpa Gu, Seoul, Korea, Republic of
Summary
The estimated value of insider holdings of Hanmi Pharmaceutical Co., Ltd. is at least $102K dollars as of March 20, 2025. Hanmi Pharmaceutical Co., Ltd. is the 10%+ Owner of Aptose Biosciences Inc. and owns shares of Aptose Biosciences Inc. (APTOF) stock worth about $102K.
Signature
HANMI PHARMACEUTICAL CO., LTD.; By: /s/ Haegon Shin, Managing Director, Global Business Division
All Insider Reports
All Insider Reports

Ownership of Hanmi Pharmaceutical Co., Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APTOF Aptose Biosciences Inc. 10%+ Owner $102K Mar 18, 2025

There are no insider transactions reported by Hanmi Pharmaceutical Co., Ltd.